Long-term outcome following laser therapy of benign cystic-solid thyroid nodules

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Long-term outcome following laser therapy of benign cystic-solid thyroid nodules. / Døssing, Helle; Bennedbæk, Finn Noe; Hegedüs, Laszlo.

In: Endocrine Connections, Vol. 8, No. 7, 07.2019, p. 846-852.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Døssing, H, Bennedbæk, FN & Hegedüs, L 2019, 'Long-term outcome following laser therapy of benign cystic-solid thyroid nodules', Endocrine Connections, vol. 8, no. 7, pp. 846-852. https://doi.org/10.1530/EC-19-0236

APA

Døssing, H., Bennedbæk, F. N., & Hegedüs, L. (2019). Long-term outcome following laser therapy of benign cystic-solid thyroid nodules. Endocrine Connections, 8(7), 846-852. https://doi.org/10.1530/EC-19-0236

Vancouver

Døssing H, Bennedbæk FN, Hegedüs L. Long-term outcome following laser therapy of benign cystic-solid thyroid nodules. Endocrine Connections. 2019 Jul;8(7):846-852. https://doi.org/10.1530/EC-19-0236

Author

Døssing, Helle ; Bennedbæk, Finn Noe ; Hegedüs, Laszlo. / Long-term outcome following laser therapy of benign cystic-solid thyroid nodules. In: Endocrine Connections. 2019 ; Vol. 8, No. 7. pp. 846-852.

Bibtex

@article{c644d0ee2f704600a998ceb32c7afc01,
title = "Long-term outcome following laser therapy of benign cystic-solid thyroid nodules",
abstract = "Objective: Laser therapy (LT) is considered a safe and effective procedure for inducing thyroid nodule necrosis, fibrosis and shrinkage. Little is known about long-term efficacy of LT in benign complex thyroid nodules, which we report here. Design and methods: One hundred and ten euthyroid outpatients (28 men and 82 women; median age 48 years (range 17–82)) with a recurrent cytologically benign cystic (≥2 mL cyst volume) thyroid nodule causing local discomfort were assigned to LT. LT was performed after complete cyst aspiration and under continuous ultrasound (US) guidance. Nineteen patients (17 within 6 months) had surgery after LT. The median follow-up for the remaining 91 patients was 45 months (range: 12–134). Results: The overall median nodule volume in the 110 patients decreased from 9.0 mL (range: 2.0–158.0) to 1.2 mL (range: 0.0–85.0) (P < 0.001) at the final evaluation, corresponding to a median reduction of 85% (range: −49 to 100%). Remission of the cystic part (volume ≤1 mL) was obtained in 82 of 110 (75%) patients after LT. The median cyst volume decreased from 6.3 mL (range: 2.0–158.0) to 0.0 mL (range: 0.0–85.0) (P < 000.1), corresponding to a median reduction of 100% (range: −49 to 100%). These results correlated with a significant decrease in pressure as well as cosmetic complaints. Side effects were restricted to mild local pain. Conclusion: US-guided aspiration and subsequent LT of benign recurrent cystic thyroid nodules results in a satisfactory long-term clinical response in the majority of patients. LT constitutes a clinically relevant alternative to surgery in such patients.",
keywords = "Cystic thyroid nodule, Laser therapy, Long-term follow-up, Ultrasound",
author = "Helle D{\o}ssing and Bennedb{\ae}k, {Finn Noe} and Laszlo Heged{\"u}s",
year = "2019",
month = jul,
doi = "10.1530/EC-19-0236",
language = "English",
volume = "8",
pages = "846--852",
journal = "Endocrine Connections",
issn = "2049-3614",
publisher = "BioScientifica Ltd.",
number = "7",

}

RIS

TY - JOUR

T1 - Long-term outcome following laser therapy of benign cystic-solid thyroid nodules

AU - Døssing, Helle

AU - Bennedbæk, Finn Noe

AU - Hegedüs, Laszlo

PY - 2019/7

Y1 - 2019/7

N2 - Objective: Laser therapy (LT) is considered a safe and effective procedure for inducing thyroid nodule necrosis, fibrosis and shrinkage. Little is known about long-term efficacy of LT in benign complex thyroid nodules, which we report here. Design and methods: One hundred and ten euthyroid outpatients (28 men and 82 women; median age 48 years (range 17–82)) with a recurrent cytologically benign cystic (≥2 mL cyst volume) thyroid nodule causing local discomfort were assigned to LT. LT was performed after complete cyst aspiration and under continuous ultrasound (US) guidance. Nineteen patients (17 within 6 months) had surgery after LT. The median follow-up for the remaining 91 patients was 45 months (range: 12–134). Results: The overall median nodule volume in the 110 patients decreased from 9.0 mL (range: 2.0–158.0) to 1.2 mL (range: 0.0–85.0) (P < 0.001) at the final evaluation, corresponding to a median reduction of 85% (range: −49 to 100%). Remission of the cystic part (volume ≤1 mL) was obtained in 82 of 110 (75%) patients after LT. The median cyst volume decreased from 6.3 mL (range: 2.0–158.0) to 0.0 mL (range: 0.0–85.0) (P < 000.1), corresponding to a median reduction of 100% (range: −49 to 100%). These results correlated with a significant decrease in pressure as well as cosmetic complaints. Side effects were restricted to mild local pain. Conclusion: US-guided aspiration and subsequent LT of benign recurrent cystic thyroid nodules results in a satisfactory long-term clinical response in the majority of patients. LT constitutes a clinically relevant alternative to surgery in such patients.

AB - Objective: Laser therapy (LT) is considered a safe and effective procedure for inducing thyroid nodule necrosis, fibrosis and shrinkage. Little is known about long-term efficacy of LT in benign complex thyroid nodules, which we report here. Design and methods: One hundred and ten euthyroid outpatients (28 men and 82 women; median age 48 years (range 17–82)) with a recurrent cytologically benign cystic (≥2 mL cyst volume) thyroid nodule causing local discomfort were assigned to LT. LT was performed after complete cyst aspiration and under continuous ultrasound (US) guidance. Nineteen patients (17 within 6 months) had surgery after LT. The median follow-up for the remaining 91 patients was 45 months (range: 12–134). Results: The overall median nodule volume in the 110 patients decreased from 9.0 mL (range: 2.0–158.0) to 1.2 mL (range: 0.0–85.0) (P < 0.001) at the final evaluation, corresponding to a median reduction of 85% (range: −49 to 100%). Remission of the cystic part (volume ≤1 mL) was obtained in 82 of 110 (75%) patients after LT. The median cyst volume decreased from 6.3 mL (range: 2.0–158.0) to 0.0 mL (range: 0.0–85.0) (P < 000.1), corresponding to a median reduction of 100% (range: −49 to 100%). These results correlated with a significant decrease in pressure as well as cosmetic complaints. Side effects were restricted to mild local pain. Conclusion: US-guided aspiration and subsequent LT of benign recurrent cystic thyroid nodules results in a satisfactory long-term clinical response in the majority of patients. LT constitutes a clinically relevant alternative to surgery in such patients.

KW - Cystic thyroid nodule

KW - Laser therapy

KW - Long-term follow-up

KW - Ultrasound

U2 - 10.1530/EC-19-0236

DO - 10.1530/EC-19-0236

M3 - Journal article

C2 - 31163398

AN - SCOPUS:85069700161

VL - 8

SP - 846

EP - 852

JO - Endocrine Connections

JF - Endocrine Connections

SN - 2049-3614

IS - 7

ER -

ID: 241479504